TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
REC Stock 12 Month Forecast
Average Price Target
€58.50
▲(20.17% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Recordati Industria Chimica e Farmaceutica SPA in the last 3 months. The average price target is €58.50 with a high forecast of €70.00 and a low forecast of €50.00. The average price target represents a 20.17% change from the last price of €48.68.
Recordati SpA (REC:IM) (RCDTF) PT Raised to EUR55 at Deutsche BankDeutsche Bank analyst Niall Alexander raised the price target on Recordati SpA (REC:IM) (OTC: RCDTF) to EUR55.00 (from EUR52.00) while maintaining a Hold rating.
Recordati SpA (REC:IM) (RCDTF) PT Raised to EUR55 at Deutsche BankDeutsche Bank analyst Niall Alexander raised the price target on Recordati SpA (REC:IM) (OTC: RCDTF) to EUR55.00 (from EUR52.00) while maintaining a Hold rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of -0.02% per trade.
trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of -0.32% per trade.
Copying Charles Pitman CFA's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of -5.22% per trade.
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of -4.08% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
REC Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
3
2
1
0
1
Hold
9
8
7
5
5
Sell
1
1
1
1
1
Strong Sell
0
0
0
0
0
total
13
11
9
6
7
In the current month, REC has received 1Buy Ratings, 5Hold Ratings, and 1Sell Ratings. REC average Analyst price target in the past 3 months is 58.50.
Each month's total comprises the sum of three months' worth of ratings.
REC Financial Forecast
REC Earnings Forecast
The previous quarter’s earnings for REC were €0.79.
The previous quarter’s earnings for REC were €0.79.
REC Sales Forecast
Next quarter’s sales forecast for REC is €683.90M with a range of €683.90M to €683.90M. The previous quarter’s sales results were €632.32M. REC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year REC has Performed in-line its overall industry.
Next quarter’s sales forecast for REC is €683.90M with a range of €683.90M to €683.90M. The previous quarter’s sales results were €632.32M. REC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year REC has Performed in-line its overall industry.
REC Stock Forecast FAQ
What is IT:REC’s average 12-month price target, according to analysts?
Based on analyst ratings, Recordati Industria Chimica e Farmaceutica SPA’s 12-month average price target is 58.50.
What is IT:REC’s upside potential, based on the analysts’ average price target?
Recordati Industria Chimica e Farmaceutica SPA has 20.17% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Recordati Industria Chimica e Farmaceutica SPA a Buy, Sell or Hold?
Recordati Industria Chimica e Farmaceutica SPA has a consensus rating of Hold, which is based on 1 buy ratings, 1 hold ratings and 1 sell ratings.
What is Recordati Industria Chimica e Farmaceutica SPA’s share price target?
The average share price target for Recordati Industria Chimica e Farmaceutica SPA is 58.50. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is €70.00 ,and the lowest forecast is €50.00. The average share price target represents 20.17% Increase from the current price of €48.68.
What do analysts say about Recordati Industria Chimica e Farmaceutica SPA?
Recordati Industria Chimica e Farmaceutica SPA’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Recordati Industria Chimica e Farmaceutica SPA?
To buy shares of IT:REC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.